Anixa Biosciences, Inc.
ANIX
$2.79
$0.176.49%
NASDAQ
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 13.69M | 14.20M | 15.17M | 16.03M | 15.60M |
| Total Receivables | 56.00K | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 950.00K | 848.00K | 713.00K | 1.42M | 1.17M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 14.69M | 15.05M | 15.89M | 17.45M | 16.77M |
|
|
|||||
| Total Current Assets | 14.69M | 15.05M | 15.89M | 17.45M | 16.77M |
| Net Property, Plant & Equipment | 173.00K | 183.00K | 193.00K | 202.00K | 211.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 14.87M | 15.23M | 16.08M | 17.65M | 16.98M |
|
|
|||||
| Total Accounts Payable | 252.00K | 148.00K | 165.00K | 276.00K | 284.00K |
| Total Accrued Expenses | 1.21M | 1.05M | 1.76M | 1.75M | 1.57M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 44.00K | 42.00K | 41.00K | 39.00K | 37.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.50M | 1.24M | 1.97M | 2.07M | 1.89M |
|
|
|||||
| Total Current Liabilities | 1.50M | 1.24M | 1.97M | 2.07M | 1.89M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 140.00K | 151.00K | 163.00K | 174.00K | 184.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.64M | 1.39M | 2.13M | 2.24M | 2.07M |
|
|
|||||
| Common Stock & APIC | 271.23M | 269.32M | 266.84M | 265.58M | 262.79M |
| Retained Earnings | -256.76M | -254.24M | -251.68M | -248.98M | -246.72M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 14.48M | 15.08M | 15.16M | 16.60M | 16.07M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 14.48M | 15.08M | 15.16M | 16.60M | 16.07M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -1.25M | -1.23M | -1.21M | -1.18M | -1.16M |
| Total Equity | 13.22M | 13.85M | 13.95M | 15.41M | 14.91M |
|
|
|||||